Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector

Investigator(s):
Gary Schiller, M.D.;
Organization: 
UCLA
NCT Number: 
Disease Name: 
Sickle Cell Disease
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Trial Contact: 

Fabrizia Urbinati, Ph.D. 
(310) 794-1884 
furbinati@ucla.edu